| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019914334 |
| P356 | DOI | 10.1007/S12630-013-9915-9 |
| P698 | PubMed publication ID | 23512191 |
| P5875 | ResearchGate publication ID | 236064368 |
| P2093 | author name string | Kevin D Johnston | |
| Mridula R Rai | |||
| P2860 | cites work | Complete airway obstruction during awake fibreoptic intubation. | Q51541614 |
| Measured context-sensitive half-times of remifentanil and alfentanil. | Q51591468 | ||
| A technique of awake fibreoptic intubation. Experience in patients with cervical spine disease. | Q51654450 | ||
| Effects of alfentanil on the responses to awake fiberoptic nasotracheal intubation. | Q51741777 | ||
| Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability. | Q51910931 | ||
| Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. | Q52028622 | ||
| Laryngeal incompetence during neuroleptanalgesia in combination with diazepam | Q52712186 | ||
| The effects of increasing plasma concentrations of dexmedetomidine in humans | Q28141747 | ||
| Frequent hypoxemia and apnea after sedation with midazolam and fentanyl | Q28329678 | ||
| Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit | Q28377548 | ||
| Awake endotracheal intubation: a review of 267 cases | Q34426549 | ||
| Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series | Q36102586 | ||
| Dexmedetomidine for an awake fiber-optic intubation of a parturient with Klippel-Feil syndrome, Type I Arnold Chiari malformation and status post released tethered spinal cord presenting for repeat cesarean section | Q37694334 | ||
| Progress in management of the obstructed airway | Q37954685 | ||
| Complications of awake fibreoptic intubation without sedation in 200 healthy anaesthetists attending a training course | Q39211351 | ||
| Interactions between midazolam and remifentanil during monitored anesthesia care | Q41270390 | ||
| Awake fibreoptic intubation in the patient at high risk of aspiration | Q42078736 | ||
| Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers | Q42165627 | ||
| Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports. | Q42980130 | ||
| Dexmedetomidine for awake fibreoptic intubation and awake self-positioning in a patient with a critically located cervical lesion for surgical removal of infra-tentorial tumour | Q43009489 | ||
| Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients. | Q43094727 | ||
| A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation | Q43141078 | ||
| A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation | Q43182886 | ||
| Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery. | Q43280537 | ||
| Fiberoptic intubation during remifentanil propofol sedation | Q43609494 | ||
| Difficult airway management in a patient with severe aortic stenosis, coronary artery disease, and heart failure | Q43954265 | ||
| Evaluation of remifentanil as single drug for awake fiberoptic intubation | Q43958800 | ||
| Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck | Q43958847 | ||
| Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). | Q44338196 | ||
| Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation | Q44491367 | ||
| Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application | Q44503125 | ||
| Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. | Q44559175 | ||
| Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases | Q44863277 | ||
| Total airway obstruction during local anesthesia in a non-sedated patient with a compromised airway | Q45094956 | ||
| A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation | Q46118463 | ||
| Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients | Q46118470 | ||
| Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery | Q46450327 | ||
| Dexmedetomidine is a useful adjunct for awake intubation | Q46652842 | ||
| Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient | Q46654664 | ||
| Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements | Q46726877 | ||
| Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial | Q46882774 | ||
| Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy | Q48265245 | ||
| Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication | Q48276083 | ||
| The use of propofol and remifentanil for the anaesthetic management of a super-obese patient | Q48582646 | ||
| Awake fibrecapnic intubation in head and neck cancer patients with difficult airways: new findings and refinements to the technique. | Q48621732 | ||
| Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections | Q48894237 | ||
| Training course in local anaesthesia of the airway and fibreoptic intubation using course delegates as subjects | Q49025595 | ||
| Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. | Q50977804 | ||
| Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations. | Q51451985 | ||
| Complete upper airway obstruction during awake fibreoptic intubation in patients with unstable cervical spine fractures. | Q51469336 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 584-599 | |
| P577 | publication date | 2013-03-20 | |
| P1433 | published in | Canadian Journal of Anaesthesia | Q2511577 |
| P1476 | title | Conscious sedation for awake fibreoptic intubation: a review of the literature | |
| P478 | volume | 60 |
| Q90642068 | A Comparative Study of Midazolam Alone or in Combination with Dexmedetomidine or Clonidine for Awake Fiberoptic Intubation |
| Q41891860 | A comparison of dexmedetomidine plus ketamine combination with dexmedetomidine alone for awake fiberoptic nasotracheal intubation: A randomized controlled study |
| Q38707203 | A prospective cohort study of awake fibreoptic intubation practice at a tertiary centre |
| Q91662555 | Assessment of awake i-gel™ insertion for fiberoptic-guided intubation in patients with predicted difficult airway: A prospective, observational study |
| Q58595076 | Awake fiberoptic nasotracheal intubation for patients with difficult airway |
| Q36117495 | Awake intubation creates feelings of being in a vulnerable situation but cared for in safe hands: a qualitative study |
| Q47281157 | Current practice for awake fibreoptic intubation - some unanswered questions |
| Q33564671 | Dexmedetomidine decreases requirement of thiopentone sodium and pentazocine followed with improved recovery in patients undergoing laparoscopic cholecystectomy |
| Q36667685 | Dexmedetomidine provides optimum conditions during awake fiberoptic intubation in simulated cervical spine injury patients |
| Q42155267 | Doxapram hastens the recovery following total intravenous anesthesia with dexmedetomidine, propofol and remifentanil |
| Q64290941 | Efficacy of Adding Low-Dose Ketamine to Dexmedetomidine Versus Low-Dose Ketamine and Propofol for Conscious Sedation in Patients Undergoing Awake Fiber-optic Intubation |
| Q97423257 | Evaluation of retrograde intubation with different doses of dexmedetomidine infusion: A randomised controlled trial |
| Q64084904 | Fibreoptic intubation in airway management: a review article |
| Q55400216 | Hemodynamic Responses and Safety of Sedation Following Premedication with Dexmedetomidine and Fentanyl during Fiberoptic-assisted Intubation in Patients with Predicted Difficult Airway. |
| Q35443541 | Sedation options for the morbidly obese intensive care unit patient: a concise survey and an agenda for development |
| Q45805622 | Successful intubation of a difficult airway due to a large obstructive vocal cord polyp augmented by the delivery of a transtracheal injection of local anaesthetic. |
| Q55456526 | The association of body mass index with difficult tracheal intubation management by direct laryngoscopy: a meta-analysis. |
Search more.